Canadian Investigational & Special Access Drug List (CISADL)

Canadian Investigational & Special Access Drug List (CISADL) 2017

The Canadian Investigational and Special Access Drug List is a compilation of drugs that are currently not marketed in Canada, and may have Investigational or Special Access status with Health Canada. This list is not endorsed by Health Canada’s Special Access Program. For precise information about the regulatory status of a drug, contact the Special Access Program directly. Entries to the list are contributed to by several Drug Information Centres across Canada and by Canadian drug manufacturers. In cases where non-marketed drugs do not appear on the list, foreign references should be consulted. The content of the list includes generic name and strength/concentration, dosage form, pharmacology/therapeutic use, trade and code name, source (manufacturer/distributor), and comments.

Available in English only/Disponible en anglais seulement.

Please take note that CSHP did not publish CISADL in 2018 and 2019.

Canadian Investigational & Special Access Drug List (CISADL) 2017

(2017; loose leaf, three hole punched)

CSHP member price


Full price



Order Form

*Please add $4.34 shipping and handling for one copy of this publication. (Shipping costs may increase for  additional copies and extended locations.) Prices are subject to GST/HST where applicable.

For more information, please contact the CSHP National Office. Phone: 613-736-9733 Ext. 228.